Xelucip 120, Relugolix, AntiCancer Drugs, Prostate Cancer, Online Pharmacy
AntiCancer Drugs HORMONES Menstrual Irreg./Dysmen. Uterine Fibroid Endometriosis Prostate Cancer

Xelucip 120

★★★★★
★★★★★
0

(0)

Generic For ORGOVYX
Active Ingredient RELUGOLIX
Strength 120MG
Manufacturer CIPLA
Xelucip 120 30 tablets box packaging relugolix endometriosis treatment medicine online pharmacy
Xelucip 120 30 tablets bottle and box relugolix hormone therapy online pharmacy
Xelucip 120 30 tablets branded box relugolix oral medicine for endometriosis online pharmacy
Xelucip 120 30 tablets box packaging relugolix endometriosis treatment medicine online pharmacy
Xelucip 120 30 tablets bottle and box relugolix hormone therapy online pharmacy
Xelucip 120 30 tablets branded box relugolix oral medicine for endometriosis online pharmacy
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
1 BOX - 30 TABLETS $ 6.78 $ 203.40
$ 172.89
Apply ZARVY26 (-15%)
You save $ 30.51
2 BOXES - 60 TABLETS $ 6.52
4% $ 406.80
$ 391.20
$ 332.52
Apply ZARVY26 (-15%)
You save $ 58.68
★ Best Value 3 BOXES - 90 TABLETS $ 6.36
6% $ 610.20
$ 572.40
$ 486.54
Apply ZARVY26 (-15%)
You save $ 85.86

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Xelucip 120 is an oral medication containing 120 mg of Relugolix, a non-peptide GnRH receptor antagonist used in the management of advanced prostate cancer. Unlike GnRH agonists, Relugolix provides immediate suppression of testosterone without causing a transient androgen flare. This allows for a faster therapeutic response and reduces the risk of symptom worsening, such as bone pain or urinary obstruction. Its oral formulation also offers a convenient alternative to injectable therapies.

Indications & Uses

  • AntiCancer Drugs > Prostate Cancer
    Xelucip 120 is indicated for the treatment of adult men with advanced prostate cancer, including nonmetastatic and metastatic cases. It is especially beneficial for patients who require continuous androgen deprivation therapy (ADT) and prefer oral administration over injections. By directly inhibiting GnRH receptors in the pituitary gland, Relugolix reduces the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), resulting in rapid suppression of testosterone, which is critical in controlling prostate cancer growth.

Benefits & Effectiveness

  • Blocks GnRH receptors, rapidly suppressing LH and FSH release from the pituitary
  • Swift reduction of serum testosterone to castrate levels, usually within days
  • Avoids the initial testosterone surge seen with GnRH agonists, preventing tumor flare
  • Demonstrated improved cardiovascular safety profile in clinical trials
  • Suitable for both hormone-sensitive and castration-resistant prostate cancer

Directions for Use

  • Dosage & Administration
    Prostate Cancer (Adults): Loading Dose is 360 mg orally once on Day 1. Maintenance Dose is 120 mg orally once daily starting Day 2. Tablets should be taken at the same time every day, with or without food. Swallow whole; do not crush or chew. Continuous therapy is required to maintain castrate levels of testosterone.
  • Key Points
    Confirm diagnosis of advanced or metastatic prostate cancer before initiation. Evaluate serum testosterone periodically to ensure adequate suppression. Consider bone density monitoring during prolonged therapy. If a dose is missed, take it as soon as remembered on the same day; do not double the next dose.

Storage

Store Xelucip 120 in a dry place at a temperature below 30°C. Keep in original packaging until use to protect from moisture and light. Do not refrigerate. Keep out of reach of children and dispose of unused tablets according to local regulations.

Possible Side Effects

Common side effects include hot flashes, fatigue, diarrhea, constipation, and musculoskeletal pain. Long-term use may result in decreased bone mineral density, metabolic changes, or reduced libido. Less frequently, patients may experience anemia, increased liver enzymes, or cardiovascular events. Monitoring for these effects is advised, particularly in elderly patients or those with pre-existing conditions.

FAQs

Xelucip 120 suppresses testosterone levels by blocking GnRH receptors, which is essential for slowing the growth of hormone-sensitive prostate cancer.
Clinical trials suggest Relugolix may have a lower risk of cardiovascular events compared to GnRH agonists, making it a safer choice for some patients.
No. Continuous therapy is required to maintain testosterone suppression and prevent cancer progression. Always consult your doctor before making changes.
Take the missed dose as soon as possible on the same day. If you remember the next day, skip the missed dose and continue with the regular schedule. Do not take two doses at once.
Yes. Relugolix is used in both castration-sensitive and castration-resistant prostate cancer. Its rapid testosterone suppression is beneficial in both contexts.

Ratings & Reviews

Reviewed by 0 Users

0/5
★★★★★
★★★★★
5★
0%
4★
0%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

No reviews yet. Be the first to review this product!

Alternatives

Combo Deals

No combo deals available at the moment.